Notícias e Atividades da Canopy Growth

Canopy Growth é uma empresa listada sob o símbolo WEED (CA).

Canopy Growth tem presença direta em 2 países.

Veja o organograma con seus 46 executivos principais

Biografias mais buscadas da Canopy Growth

• Luc Mongeau, Chief Executive Officer and Director
• Shan Atkins, Director
• David Lazzarato, Chairman of the Board

Recentes movimentos de executivos em Canopy Growth

• Michael Perron, ingressou na Companhia como Chief Operating Officer  (Notícia publicada em 16 de abril de 2026).
• Serge Lojo antes Head of Government Board Sales, foi promovido a Vice President of Sales  (Notícia publicada em 16 de abril de 2026).
• David Männer atualmente Deputy Managing Director, Storz and Bickel, será promovido a Managing Director of Storz and Bickel em 1 de abr. de 2026  (Notícia publicada em 27 de março de 2026).

Clique aqui para ver outras movimentos em Canopy Growth

Criar um alerta
para seguir os movimentos de executivos da Canopy Growth.

Canopy Growth possui 110 concorrentes concorrentes Philip Morris International (Estados Unidos), British American Tobacco (Reino Unido) e Imperial Brands (Reino Unido).

Popular M&A news in Tabaco

• Vireo Growth has announced the acquisition of Fluent Corp  (publicado em 11 de maio de 2026).
• Unrivaled has filed for bankruptcy protection  (publicado em 4 de junho de 2025).
• O novo nome de Fluent é Fluent. (publicado em 6 de fevereiro de 2025).

Outros contatos sugeridos na indústria do Tabaco

• Salvatore Mancuso - Chief Executive Officer and Director da Altria
• Patrick Picavet - Chief Medical Officer da Philip Morris International
• Szymon Myslinski - Vice President of Enterprise Artificial Intelligence and Architecture da Philip Morris International

Saiba mais sobre a indústria do Tabaco

Últimos comunicados de imprensa de Canopy Growth

• Canopy Growth Provides Update on Financial Reporting and Announces Fourth Quarter and Fiscal Year 2026 Financial Results to be Presented on June 15, 2026 - Canopy Growth
• Canopy Growth and Spectrum Therapeutics Expand Medical Portfolio with New 30 and 90-Pack Softgels and Enhanced Dosing Options - Canopy Growth
• ‘There’s a Tweed for That’: Canopy Growth Announces Tweed Brand Summer Campaign - Canopy Growth
• CANOPY GROWTH UNVEILS NEW BRAND ‘DEELISH’: HIGH THC, EVERYDAY PRICE - Canopy Growth
• CANOPY GROWTH’S APOLLO CANNABIS CLINICS NAMED BEST MEDICAL CANNABIS CLINIC - Canopy Growth
• CANOPY GROWTH ANNOUNCES STORZ & BICKEL EXECUTIVE TRANSITION - Canopy Growth
• Canopy Growth Completes Acquisition of MTL Cannabis Creating Canada’s Leading Medical Cannabis Business By Revenue - Canopy Growth
• Canopy Growth Announces MTL Cannabis Shareholder Approval of Acquisition - Canopy Growth
• Canopy Growth Reports Third Quarter Fiscal 2026 Financial Results; Delivers double digit net revenue growth in Canada Cannabis contributing to a narrowing net loss; financial strength of $371M in cash and cash equivalents with a net cash position of $146M
• Canopy Growth to Report Third Quarter Fiscal 2026 Financial Results on February 6, 2026 - Canopy Growth
• View more press releases Close

Redes sociais sobre Canopy Growth

• Canopy Growth na Wikipedia, Google News e Yahoo Finance
• Canopy Growth na LinkedIn, X (Twitter) e YouTube